Abstract:A number of studies have attempted to elucidate the association between mircoRNAs (miRNAs/miRs) and cancer-associated processes. The aim of the present study was to determine how miR-499a-5p intervenes in human osteosarcoma cell proliferation and differentiation. The cancerous tissues and adjacent non-cancerous tissues of 62 patients with osteosarcoma (OS) were collected. miRNA microarray analysis revealed that 29 miRNAs were upregulated while 26 were downregulated, among which miR-499a-5p expression was the most decreased. Western blot analysis and reverse transcription-quantitative polymerase chain reaction demonstrated that the mRNA and protein expression of miR-499a-5p was lower, while that of protein phosphatase 1D (PPM1D) was higher in OS tissues compared with expression levels in normal tissues. Furthermore, miR-499a-5p expression was markedly decreased in the metastatic tumors and in those at stage III+ IV compared with the non-metastatic tumors and those at stage I, respectively. In addition, following transfection of the human OS MG-63 cell line with an miR-499a-5p mimic, the expression of miR-499a-5p was elevated while the protein and mRNA expression of PPM1D was decreased. When combining these findings with the information obtained from the Targetscan predictive software, it was confirmed that PPM1D was targeted by miR-499a-5p. In MG-63 cells transfected with an miR-499a-5p mimic, PPM1D-associated downstream proteins phosphorylated protein kinase B (p-Akt) and phosphorylated glycogen synthase kinase 3 beta (p-GSK-3 beta) were significantly downregulated compared with the negative control (NC) group, while the expression of p-Akt and p-GSK-3 beta were significantly elevated in the tumor tissues compared with the adjacent non-tumor tissues. Simultaneously, the growth and proliferation activity of MG-63 cells were notably reduced when transfected with the miR-499a-5p mimic, compared with the NC group. Therefore, it may be concluded that miR-499a-5p suppresses OS cell proliferation and differentiation by targeting PPM1D through modulation of Akt/GSK-3 beta signaling.

Mir-513A-5p Regulates Radiosensitivity of Osteosarcoma by Targeting Human Apurinic/apyrimidinic Endonuclease.

Mir-214 Modulates Cisplatin Sensitivity of Osteosarcoma Cells Through Regulation of Anaerobic Glycolysis.

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma.

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

Mir-205 Acts As a Tumour Radiosensitizer by Targeting ZEB1 and Ubc13

Mechanism Of Mir-512-5p To Promote Radiotherapy Sensitivity Of Lung Cancer By Targeting Sod2

Mir-574-3p Acts As a Tumor Promoter in Osteosarcoma by Targeting SMAD4 Signaling Pathway

Mir-193B Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy

Mir-335 Negatively Regulates Osteosarcoma Stem Cell-Like Properties by Targeting POU5F1

Mir‑15a Represses Cancer Cell Migration and Invasion under Conditions of Hypoxia by Targeting and Downregulating Bcl‑2 Expression in Human Osteosarcoma Cells.

Tumor-Suppressing Effects of Mir-429 on Human Osteosarcoma

MiR-138 Acts As a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells

Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis

MiR-34a and Mir-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells

Mir-16-5p Suppresses Progression and Invasion of Osteosarcoma Via Targeting at Smad3

Mir-140-5p Attenuates Chemotherapeutic Drug-Induced Cell Death by Regulating Autophagy Through Inositol 1,4,5-Trisphosphate Kinase 2 (ip3k2) in Human Osteosarcoma Cells

Mir-504 Promotes Tumour Growth and Metastasis in Human Osteosarcoma by Targeting TP53INP1

MicroRNA-433 Regulates Apoptosis by Targeting PDCD4 in Human Osteosarcoma Cells.

Microrna-499a-5p Inhibits Osteosarcoma Cell Proliferation And Differentiation By Targeting Protein Phosphatase 1d Through Protein Kinase B/Glycogen Synthase Kinase 3 Beta Signaling

Microrna-18a Inhibits Cell Growth And Induces Apoptosis In Osteosarcoma By Targeting Med27